Fundraising FoxFoundation Venture Capital Group, LLC — Full Portfolio
14 tracked investments · listed companies and verified rows first
NovoPedics is developing MeniscoFix, a resorbable implant placed via arthroscopically-assisted surgery to replace the entire medial or lateral meniscus of the knee, intended to relieve pain, restore mobility, and prevent osteoarthritis in patients with severe meniscal injuries.
BiotechHealthtechMedical DevicesMonmouth Junction, US
Charles J. Gatt, Jr., MD(Founder & CEO)Michael G. Dunn, PhD(Founder & Secretary/Treasurer)Kevin Weadock, PhD(Chief Operating Officer)
Zena Therapeutics is a therapeutics company developing drug candidates, with work spanning molecular design, pharmacology, animal studies, and clinical trial design toward IND submission.
BiotechHealthtechMental HealthPrinceton, US
Eileen Carry, PhD(Founder)inEileen Carry(Chief Scientific Officer | co-Founder)Ariane Vasilatis(Chief Executive Officer | co-Founder)
Durin Technologies (Durin Life Sciences) develops Duritect blood tests that combine autoantibody biomarkers with machine learning to assess a patient's risk of Alzheimer's disease and Parkinson's disease.
AI & Machine LearningBiotechDigital HealthStratford, US
Mert Sahin(Executive Officer)Benjamin A. Belinka, Jr.(Executive Officer)
BoardRobert Nagele(Director)Rene Chaze(Director)
Kayo Therapeutics is a biotechnology company developing therapeutics, with a scientific and clinical focus that includes areas such as metabolic disease and oncology.
BiotechHealthtechSeattle, US
Mark Esposito(CSO, Co-Founder and Board Member)inYibin Kang(Chair, Scientific Advisory Board and Co-Founder)Kendall Mohler(Executive Officer, Director)Thong Q. Le(President and CEO, Board Member)Ian Howes(Chief Financial Officer)Merika Koday(COO and Board Member)in
Co-investors7G BioVenturesBioAdvance
Focused on longevity technologies; Foundation sold its equity interest to Rostock International, Ltd.
Co-investorsXploration Capital
NemaGen Discoveries develops first-in-class therapies targeting mast cell-related diseases and chronic inflammation by leveraging insights from studying the body's natural inflammatory response to parasitic infections.
BiotechDigital HealthHealthtechMedical Devices
Mark(Associate Professor in the Department of Medicine and the Center for Immunity and Inflammation at Rutgers New Jersey Medical School)Martin(Chief Executive Officer)
Mattek develops human-relevant in vitro research products, including lab-grown 3D human epithelial tissue models, banks of primary human cells, and cell culture dishes and plates optimized for cell growth and imaging.
BiotechHealthtechNew Materials
Michael Johnson(Cofounder)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ActinobacActinobac BiomedEValuate Diagnostics, Inc.KairosventuresMentiNovaUpstream Access, Inc.Zena Therapeutic
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.